Citation: | YAN Quanxiang, FENG Li, XU Feng, et al. Thrombolytic Effect of Nattokinase and Its Mechanism[J]. Science and Technology of Food Industry, 2021, 42(24): 340−346. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2021030178. |
[1] |
WANG Y, GAO H, C W KESSINGER, et al. Myeloid-related protein-14 regulates deep vein thrombosis[J]. Jci Insight,2017,2(11):1−12.
|
[2] |
刘泽霖, 贺石林, 李家增. 血栓性疾病的诊断与治疗[M]. 北京: 人民卫生出版社, 2006: 115−116.
LIU Z L, HE S L, LI J Z. Diagnosis and treatment of thrombotic diseases[M]. Beijing: People’s Medical Publishing House, 2006: 115−116.
|
[3] |
WANG W, JIANG B, SUN H, et al. Prevalence, incidence, and mortality of stroke in China[J]. Circulation,2017,35(13):759−771.
|
[4] |
WU Y, BENJAMIN E J, MACMAHON S. Prevention and control of cardiovascular disease in the rapidly changing economy of China[J]. Circulation,2016,133(24):2545−2560. doi: 10.1161/CIRCULATIONAHA.115.008728
|
[5] |
王春霞. 抗血栓药物研究进展[J]. 当代临床医刊,2012,25(5):86−88. [WANG C X. Research progress of antithrombotic drugs[J]. The Medical Journal of Industrial Enterprise,2012,25(5):86−88.
|
[6] |
VAN GIJN J, ALGRA A. Secondary stroke prevention with antithrombotic drugs[J]. Current Vascular Pharmacology,2010,7(Suppl.6):30−32.
|
[7] |
陈志文, 徐尔尼, 肖美燕. 纳豆激酶的研究进展[J]. 食品科学,2002,23(10):130−134. [CHEN Z W, XU E N, XIAO M Y. Research progress of nattokinase[J]. Food Science,2002,23(10):130−134. doi: 10.3321/j.issn:1002-6630.2002.10.036
|
[8] |
SUMI H, HAMADA H, NAKANISHI K, et al. Enhancement of the fibrinolytic activity in plasma by oral administration of nattokinase[J]. Acta Haematologica,1990,84(3):139−143. doi: 10.1159/000205051
|
[9] |
YASUHIDE, YANAGISAWA, TOSHIYUKI, et al. Purification, crystallization and preliminary X-ray diffraction experiment of nattokinase from Bacillus subtilis natto[J]. Acta Crystallographica,2010,F66:1670−1673.
|
[10] |
胡升, 梅乐和, 姚善泾. 响应面法优化纳豆激酶液体发酵[J]. 食品与发酵工业,2003,29(1):13−17. [HU S, MEI L H, YAO S J. Optimization of submerged fermentation of nattokinase production by Bacillus subtilis with response surface methodology[J]. Food and Fermentation Industries,2003,29(1):13−17. doi: 10.3321/j.issn:0253-990X.2003.01.004
|
[11] |
朱健辉, 杜连祥, 路福平, 等. 高效溶栓酶-纳豆激酶的纯化及酶学性质研究[J]. 微生物学通报,2006(1):68−71. [ZHU J H, DU L X, LU F P, et al. Purification and characterization of a strong fibrinolytic enzyme-nattok inase[J]. Microbiology China,2006(1):68−71. doi: 10.3969/j.issn.0253-2654.2006.01.014
|
[12] |
王俊菊, 李培锋, 关红. 纳豆激酶抗凝血作用的研究[J]. 中国生化药物杂志,2004,25(5):276−278. [WANG J J, LI P F, GUAN H. Anticoagulant effecs of nattokinase in rats[J]. Chinese Journal of Biochemical Pharmaceutics,2004,25(5):276−278. doi: 10.3969/j.issn.1005-1678.2004.05.007
|
[13] |
周伏忠, 贾蕴莉, 陈国参, 等. 纳豆激酶体外溶栓效果的初步观察[J]. 食品科技,2008,33(6):249−253. [ZHOU F Z, JIA Y L, CHEN G S, et al. A priliminary study of nattokinase thrombolysis effect in vitro[J]. Food Science and Technology,2008,33(6):249−253. doi: 10.3969/j.issn.1005-9989.2008.06.077
|
[14] |
吴少琴, 季乃军, 蓝翔. 永久性心房颤动患者血清TXB2、6-K-PGF1α和PGE2改变的探讨[J]. 放射免疫学杂志,2013,26(5):549−551. [WU S Q, JI N J, LAN X. Exploration the change of thromboxane B2, 6-keto-PGF1α and prostaglandin E2 in permanent atrial fibrillation patients[J]. Journal of Radioimmunology,2013,26(5):549−551. doi: 10.3969/j.issn.1008-9810.2013.05.003
|
[15] |
宋秀风. 银悄病和湿疹患者体内花生四烯酸代谢产物水平检测[D]. 济南: 山东大学, 2011.
SONG X F. A study of arachidonic acid metabolites in proriasis and eczema[D]. Jinan: Shandong University, 2011.
|
[16] |
HUBBARD G P, S WOLFFRAM, J A LOVEGROVE, et al. Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in humans[J]. Journal of Thrombosis & Haemostasis,2010,2(12):2138−2145.
|
[17] |
KUROSAWA Y, NIRENGI S, HOMMA T, et al. A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles[J]. Scientific Reports,2015,5:11601. doi: 10.1038/srep11601
|
[18] |
张润玲, 刘玉梅, 潘云燕, 等. 脑血栓前期血管内皮细胞损伤研究[J]. 国际检验医学杂志,2005,26(7):1−3. [ZHANG R L, LIU Y M, PAN Y Y, et al. A study on the damage of endotheliocyte in prethrombotic state with brain[J]. International Journal of Laboratory Medicine,2005,26(7):1−3.
|
[19] |
顾炜, 马贤德, 全连峰, 等. 特丁基对苯二酚抑制中波紫外线诱发HaCaT细胞氧化损伤[J]. 中国医科大学学报,2016(4):337−339. [GU W, MA X D, QUAN L F, et al. Tert-butylhydroquinone protects HaCaT cells from ultraviolet B-induced oxidative damages[J]. Journal of China Medical University,2016(4):337−339. doi: 10.12007/j.issn.0258-4646.2016.04.012
|
[20] |
甘晓, 应燕萍. 氧化应激与血栓性疾病关系的研究进展[J]. 临床心血管病杂志,2019,35(8):758−762. [GAN X, YING Y P. Research progress in the relationship between oxidative stress and thrombotic diseases[J]. Journal of Clinical Cardiology,2019,35(8):758−762.
|
[21] |
张洁. 氧化应激在高原动脉粥样硬化发生发展中的作用机制[J]. 中国民族医药杂志,2016,22(9):64−67. [ZHANG J. Mechanism of oxidative stress in the occurrence and development of atherosclerosis at high altitude[J]. Journal of Medicine and Pharmacy of Chinese Minorities,2016,22(9):64−67. doi: 10.3969/j.issn.1006-6810.2016.09.039
|
[22] |
李德卫, 赵渝, 时德, 等. 下肢血栓闭塞性脉管炎患者腰交感神经节的病理变化[J]. 医学争鸣,2003,24(24):2251−2254. [LI D W, ZHAO Y, SHI D, et al. Pathological changes of lumbar sympathetic ganglia in patients with lower extremity thromboangiitis obliterans[J]. Journal of the Fourth Military Medical University,2003,24(24):2251−2254.
|
[23] |
李延广. 阵发性心房颤动对内皮功能的影响研究[J]. 中华老年心脑血管病杂志,2015,17(12):1253−1256. [LI Y G. Effect of paroxysmal atrial fibrillation on endothelial function[J]. Chinese Journal of Geriatric Heart Brain and Vessel Diseases,2015,17(12):1253−1256. doi: 10.3969/j.issn.1009-0126.2015.12.007
|
[24] |
IWAI K, NAKAYA N, KAWASAKI Y, et al. Antioxidative functions of natto, a kind of fermented soybeans: Effect on LDL oxidation and lipid metabolism in cholesterol-fed rats[J]. Journal of Agricultural & Food Chemistry,2002,50(12):3597−3601.
|
[25] |
CHANG C H, CHEN K T, LEE T H, et al. Effects of natto extract on endothelial injury in a rat model[J]. Acta Medica Okayama,2010,64(6):399−406.
|
[26] |
李健. 纤维蛋白相关标志物在诊断和预防中的联合应用[J]. 中华检验医学杂志,2014,37(3):233−235. [LI J. Combined application of fibrin related markers in diagnosis and prevention[J]. Chinese Journal of Laboratory Medicine,2014,37(3):233−235.
|
[27] |
XU J, DU M, YANG X, et al. Thrombolytic effects in vivo of nattokinase in a carrageenan-induced rat model of thrombosis[J]. Acta Haematologica,2014,132(2):247−253. doi: 10.1159/000360360
|
[28] |
SUMI, HAMADA H, TSUSHIMA H, et al. A novel fibrinolytic enzyme(nattokinase) in the vegetable cheese Natto; a typical and popular soybean food in the Japanese diet[J]. Experientia,1987,43(10):1110−1111. doi: 10.1007/BF01956052
|
[29] |
FUJITA M, HONG K, ITO Y, et al. Thrombolytic effect of nattokinase on a chemically induced thrombosis model in rat[J]. Biological & Pharmaceutical Bulletin,1995,18(10):1387−1391.
|
[30] |
于淑红, 邢美玲. t-PA与血栓性疾病的相关性研究[J]. 中国误诊学杂志,2006,6(12):2322−2323. [YU S H, XING M L. Correlation between t-PA and thrombotic diseases[J]. Chinese Journal of Misdiagnostics,2006,6(12):2322−2323. doi: 10.3969/j.issn.1009-6647.2006.12.067
|
[31] |
陈丽娟, 沙长青, 任永春, 等. 纳豆激酶溶解血栓机制[J]. 中国生物工程杂志, 2003, 23(4): 53−56, 61.
CHEN L J, SHA CQ, REN Y C, et al. Advances in research on thrombolysis mechanism of nattokinase[J]. China Biotechnology, 2003, 23(4): 53−56, 61.
|
[32] |
韩玮, 於四军, 罗建平, 等. 急性冠脉综合征患者血清SCD40 L, Periostin, IMA, PAI-1水平改变以及心功能的研究[J]. 临床和实验医学杂志,2016,15(14):1377−1380. [HAN W, YU S J, LUO J P, et al. Changes of serum SCD40L, periostin, IMA, PAI-1 levels and cardiac function in patients with acute coronary syndrome[J]. Journal of Clinical and Experimental Medicine,2016,15(14):1377−1380. doi: 10.3969/j.issn.1671-4695.2016.14.010
|
[33] |
AMIN K, ZENG X B, YING Y, et al. Effect of pulsed electric fields(PEF) on protease and antioxidant activity of selenium modified fibrinolytic enzyme nattokinase produced by Bacillus natto cells[J]. International Journal of Biosciences,2019,14(5):282−293.
|
[34] |
KATSUTANI M, ITO T, MASAKI T, et al. Glucose-based PD solution, but not icodextrin-based pd solution, induces plasminogen activator inhibitor-1 and tissue-type plasminogen activator in human peritoneal mesothelial cells via ERK1/2[J]. Therapeutic Apheresis and Dialysis,2007,11(2):94−100. doi: 10.1111/j.1744-9987.2007.00423.x
|
[35] |
HASSANNEJAD S, RAZEGHIAN E, SHOJAEI N. Relationship between PAI1 promoter 4G/5g polymorphism and stroke[J]. Personalized Medicine,2020,5(17):18−20.
|
1. |
滕薇,刘树滔,吴金鸿,张勇. 透明质酸的制备、功能特性及其调节肠道健康的研究进展. 中国食品学报. 2024(07): 401-413 .
![]() | |
2. |
廖曦,刘雨薇,冯金华,李卡. 透明质酸水凝胶在医用导管表面改性的应用进展. 中国医疗器械杂志. 2023(02): 173-177 .
![]() | |
3. |
张泽华,刘志林,陈晨. 超小分子透明质酸功效性能测试. 日用化学品科学. 2023(05): 29-34 .
![]() | |
4. |
滕薇,刘俊辉,吴金鸿,刘树滔. 酶解—膜分离耦合连续制备抗氧化性小分子透明质酸. 食品与机械. 2023(12): 162-170 .
![]() | |
5. |
李慧凝,张京良,杨艮,江晓路. 酶法制备透明质酸寡糖及其透皮吸收活性研究. 食品工业科技. 2022(06): 77-82 .
![]() | |
6. |
石晶,冯云,包杰,樊建茹,徐桂云,范金石. 天然生物质材料的制备、性质与应用(Ⅲ)——医护两用的糖胺聚糖:透明质酸. 日用化学工业. 2022(03): 237-244 .
![]() | |
7. |
郑博文,王斌雅,肖婉玲,孙亚娟,赵炳天,杨成. 基于蛋白质组学的透明质酸寡聚糖抗炎活性研究及验证. 食品与发酵工业. 2022(14): 33-38 .
![]() | |
8. |
张洛瑜,崔云前,郝晨晓,李雅晖. 透明质酸啤酒的研究概况. 食品科技. 2022(08): 43-46 .
![]() |